Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis
- DOI
- 10.1093/ced/llad129
- Published
- 2023-04-10
- Container
- Clinical and Experimental Dermatology
- Publisher
- Oxford University Press (OUP)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1093/ced/llad129,
title = {Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis},
author = {Thomas Bieber and Jacob P Thyssen and Alan D Irvine and Yuichiro Tsunemi and Yun-Fei Chen and Luna Sun and Andrea Schloebe and Elisabeth Riedl and Michael J Cork},
year = {2023},
journal = {Clinical and Experimental Dermatology},
doi = {10.1093/ced/llad129},
url = {https://doi.org/10.1093/ced/llad129}
}RIS
TY - JOUR TI - Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis AU - Thomas Bieber AU - Jacob P Thyssen AU - Alan D Irvine AU - Yuichiro Tsunemi AU - Yun-Fei Chen AU - Luna Sun AU - Andrea Schloebe AU - Elisabeth Riedl AU - Michael J Cork PY - 2023 JO - Clinical and Experimental Dermatology DO - 10.1093/ced/llad129 UR - https://doi.org/10.1093/ced/llad129 ER -
APA
Bieber, T., Thyssen, J. P., Irvine, A. D., Tsunemi, Y., Chen, Y., Sun, L., Schloebe, A., Riedl, E., & Cork, M. J. (2023). Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llad129
Source records
- crossref · retrieved 2026-09-25T13:29:28.851Z